Release Date: 13/09/11 16:25 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 92.29KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%